Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

HomeAll NewsMost read newsBusiness Leaders Biography 
Portrait de Mardi Dier
Age : 57
Public asset : 2,765,380 USD
Country of residence : Unknown
Linked companies : Prelude Therapeutics Incorporated - ORIC Pharmaceuticals, Inc.

Biography of Mardi Dier 
Ms. Mardi C. Dier is a Chief Financial Officer & Executive Vice President at Ultragenyx Pharmaceutical, Inc., an Independent Director at Oric Pharmaceuticals, Inc. and an Independent Director at Adamas Pharmaceuticals, Inc. She is on the Board of Directors at Prelude Therapeutics, Inc., Oric Pharmaceuticals, Inc. and Adamas Pharmaceuticals, Inc. Ms. Dier was previously employed as a CFO, Chief Business Officer & Executive VP by Portola Pharmaceuticals, Inc., a Vice President-Investor Relations by Chiron Corp., a Director-Investment Banking by Prudential Equity Group LLC, a Senior Accountant by KPMG LLP, a Senior Accountant by KPMG Peat Marwick LLP, and a Director-Investment Banking by Prudential Securities. She also served on the board at Jewish Vocational Service, Inc. and Futures Strategic Trust. She received her undergraduate degree from Stanford University and an MBA from UCLA Anderson School of Management.


Current positions of Mardi Dier 
Holdings of Mardi Dier 
Mardi Dier : Personal Network 
Most Read News 
12/01Salesforce shares tumble after surprise exit of co-CEO Taylor
RE
11/23Berkshire Hathaway says Warren Buffett donates shares to family charities
RE
11/30Meta's Zuckerberg says some of Elon Musk's Twitter content approach 'might work'
RE
11/30Juventus has no requirement of additional capital, says Exor's Elkann
RE
11/30Interpol confirms red notice for Angolan billionaire Isabel dos Santos
RE
01:09aThe rise and fall of Wirecard
RE
11/22'Boomerang CEOs' don't always work out; Disney hopes this one bucks trend
RE
11/21Musk says Twitter to hold off relaunching blue check verification
RE
11/29Ryanair's O'Leary says industry most optimistic in 25 years
RE
11/25Elon Musk says Twitter's ban on Trump after Capitol attack was 'grave mistake'
RE
More news


© 2022 People and Ownership :   
Mardi Dier : Connections 


Latest news about Mardi Dier 
11/11Ultragenyx Pharmaceutical Chief Financial Officer Mardi Dier to Depart for Private Biopharma Company
MT
11/10Ultragenyx Pharmaceutical Inc. Announces Departure of Mardi Dier, Chief Financial Officer
CI
11/10Ultragenyx Pharmaceutical Inc. Announces Departure of Mardi Dier, Executive Vice President
CI
11/02Transcript : Ultragenyx Pharmaceutical Inc., Q3 2022 Earnings Call, Nov 02, 2022
CI
10/14Insider Sell: Ultragenyx Pharmaceutical
MT
07/28Transcript : Ultragenyx Pharmaceutical Inc., Q2 2022 Earnings Call, Jul 28, 2022
CI
07/18Transcript : Ultragenyx Pharmaceutical Inc. - Special Call
CI
More news